Related Articles
Role of the novel HSP90 inhibitor AUY922 in hepatocellular carcinoma: Potential for therapy
Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer
Parthenolide inhibits the tumor characteristics of renal cell carcinoma
CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway
Mechanism of tumor‑derived extracellular vesicles in regulating renal cell carcinoma progression by the delivery of MALAT1